Press Releases
Acurx Pharmaceuticals, Inc. Announces Closing of $1.1 Million Registered Direct Offering
STATEN ISLAND, N.Y., March 10, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("we" or "Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for
